Standardization of Optimized Anti-diabetic Polyherbal Formulation by HPLC
Abstract
Herbal drugs are widely used to treat and prevent various diseases with more than 80% of people worldwide relying on them for their primary healthcare. Polyherbal formulations express high effectiveness in various diseases due to their synergistic effect. Herbal formulations are required to standardize in order to assess their quality, purity, and biological efficacy. The present study aimed to prepare a polyherbal formulation comprising of lyophilized ethanolic extracts of three well known anti-diabetic herbal drugs (Momordica charantia, Andrographis paniculata and Withania somnifera), and three formulations were developed in combination ratios (1:1:1, 2:1:2, and 2:2:1) respectively and to develop high-performance liquid chromatography (HPLC) method for assessment of purity, standardization and estimation of markers. In addition, developed formulations were optimized on the basis of oral glucose tolerance test (OGTT). Standardization of developed polyherbal formulations was performed by using respective biological markers (Vicine, andrographolide, withaferin-A and withanolide-A) by HPLC technique. HPLC was performed using RP-18, Merck column to study the presence and quantification of respective markers at a wavelength of 237 nm. The HPLC study revealed the presence of vicine, andrographolide, withaferin-A, and withanolide-A in quantifiable amounts in respective extracts. OGTT study was performed using normal albino Wistar rats at a drug dose of 500 mg/kg body weight. Rats were divided into six groups, including three combination ratios and standard (Metformin) group. An optimized ratio 2:2:1 showed a significant decrease in blood glucose levels compared with standard control rats.
Keywords:
HPLC, Momordica charantia, Andrographis paniculata, Withania somnifera, Standardization.DOI
https://doi.org/10.25004/IJPSDR.2021.130207References
Baynest HW. Classification, Pathophysiology, Diagnosis and Management of Diabetes Mellitus. J Diabetes Metab. 2015; 6(5): 1-9.
Van Wijngaarden RPT, Overbeek JA, Heintjes EM, Schubert A, Diels J, Straatman H, Steyerberg EW, Herings RMC. Relation between Different Measures of Glycemic Exposure and Microvascular and Macrovascular Complications in Patients with Type 2 Diabetes Mellitus: an Observational Cohort Study. Diabetes Therap. 2017; 8:1097-1109.
Chawla A, Chawla R, Jaggi S. Microvasular and Macrovascular Complications in Diabetes Mellitus: Distinct or Continuum?. Indian J End Metab. 2016; 20: 546-553.
Ekor M. The Growing Use of Herbal Medicines: Issues Relating to Adverse Reactions and Challenges in Monitoring Safety. Front Pharmacol. 2014; 4(177): 1-10.
Yuan H, Ma Q, Ye L, Piao G. The Traditional Medicine and Modern Medicine from Natural Products. Molecules. 2016; 21(559): 1-18.
Gothai S, Ganesan P, Park S-Y, Fakurazi S, Choi D-K, Arulselvan P. Natural Phyto-bioactive Compounds for the Treatment of Type 2 Diabetes: Inflammation as a target. Nutrients. 2016; 8(8), 461: 1-28.
Che CT, Wang ZJ, Chow MSS, Lam CWK. Herb-Herb Combination for Therapeutic Enhancement and Advancement: Theory, Practice and Future Perspectives. Molecules. 2013; 18(5): 5125-5141.
Karole S, Shrivastava S, Thomas S, Soni B, Khan S, Dubey J, Dubey SP, Khan N, Jain DK. Polyherbal Formulation Concept for Synergic Action: A Review. J Drug Deliv Ther. 2019; 9(1-s): 453-466.
Sachan AK, Vishnoi G, Kumar R. Need of Standardization of Herbal Medicines in Modern Era. Int J Phytomedicine. 2016; 8: 300-307.
Gauttam V, Kalia AN. High Performance Thin Layer Chromatography Method for Simultaneous Estimation of Vicine, Trigonelline and Withaferin-A in a Polyherbal Anti-diabetic Formulation. Int J Pharm pharm Sci. 2013; 5(2): 367-371.
Huang Y, Wu Z, Su R, Ruan G, Du F, Li G. Current Application of Chemometrics in Traditional Chinese Herbal Medicine Research. J Chromatogr B. 2016; 1026: 27-35.
Kumari R, Kotecha M. A Review on the Standardization of Herbal Medicines. Int J Pharm Sci Res. 2016; 7(2): 97-106.
Jia S, Shen M, Zhang F, Xie J. Recent Advances in Momordica charantia: Functional Components and Biological Activities. Int J Mol Sci. 2017; 18(12): 1-25.
Mahmoud MFEI, Ashry FEZZ, EI Maraghy NN, Fahmy A. Studies on the Antidiabetic Activities of Momordica charantia Fruit Juice in Streptozotocin-Induced Diabetic Rats. Pharma Bio. 2017; 55 (1): 758-765.
Dia VP, Krishnan HB. BG-4, a Novel Anticancer Peptide from Bitter Gourd (Momordica charantia), Promotes Apoptosis in Human Colon Cancer Cells. Sci Rep. 2016; 6: 33532: 1-12.
Ahamad J, Amin S, Mir SR. Momordica charantia Linn. (Cucurbitaceae): Review on Phytochemistry and Pharmacology. Res J Phytochem. 2017; 11(2): 53-65.
Bhart i SK, Krishnan S, Kumar A, Kumar A. Ant idiabet ic Phytoconstituents and their Mode of Action on Metabolic Pathways. Ther Adv Endocrinol. 2018; 9(3): 81-100.
Okhuarobo A, Ehizogie Falodun J, Erharuyi O, Imieje V, Falodun A, Langer P. Harnessing the Medicinal Properties of Andrographis paniculata for Diseases and Beyond: A Review of its Phytochemistry and Pharmacology. Asian Pac J Trop Dis.2014;4(3):213-222.
Akhtar MT, Bin Mohd Sarib MS, Ismail IS, Abas F, Ismail A, Lajis NH, Shaari K. Anti-diabetic Activity and Metabolic Changes Induced by Andrographis paniculata Plant Extract in Obese Diabetic Rats. Molecules. 2016; 21(8): 1026: 1-18.
Bardi DA, Halabi MF, Hassandarvish P, Rouhollahi E, Paydar M, Moghadamtousi SZ, AI-Wajeeh NS, Ablat A, Abdullah NA, Abdulla MA. Andrographis paniculata Leaf Extract Prevents Thioacetamide- Induced Liver Cirrhosis in Rats. PLoS ONE. 2014; 9(10): e109424.
Lin H-C, Li C-C, Yang Y-C, Chiu T-H, Liu K-L, Lii C-K, Chen H-W. Andrographis paniculata Diterpenoids and Ethanolic Extract Inhibit TNFα-induced ICAM-1 Expression in EA.hy926 cells. Phytomed. 2019; 52: 157-167.
Zou W, Xiao Z, Wen X Luo J, Chen S, Cheng Z, Xiang D, Hu J, He J. The Anti-inflammatory Effect of Andrographis paniculata (Burm. f.) Nees on Pelvic Inflammatory Disease in Rats through Down-regulation of the NF-kB Pathway. BMC Complem Altern Med. 2016; 16: 483, 1-7.
Churiyah, Pongtuluran OB, Rofaani E, Tarwadi. Antiviral and Immunostimulant Activities of Andrographis paniculata. Hayati J Bio, 2015; 22(2): 67-72.
Xu J, Li Z, Cao M, Zhang H, Sun J, Zhao J, Zhou Q, Wu Z, Yang L. Synergetic effect of Andrographis paniculata Polysaccharide on Diabetic Nephropathy with Andrographolide. Int J Bio. Macro. 2012; 51(5): 738-742.
Nugroho AE, Andrie M, Warditiani N K, Siswanto E, Pramono S, Lukitaningsih E. “Anti-diabetic and antihiperlipidemic effect of Andrographis paniculata (Burm. f.) Nees and andrographolide in high fructose fat fed rats,” Indian J Pharmacol. 2012; 44(3): 377-381.
Srivastava MP, Gupta S, Dixit S, Yadav N, Yadav V, Singh H, Kanaujia P, Sharma YK. Withania somnifera (Ashwagandha): A Wonder Herb with Multiple Medicinal Properties. Asian J Pharm Pharmacol. 2018; 4(2): 123-130.
Turrini E , C alcabrini C , S estili P, C atanzaro E , d e G ianni E , D iaz AR, Hrelia P, Tacchini M, Guerrini A, Canonico B, Papa S, Valdre G, Fimognari C. Withania somnifera Induces Cytotoxic and Cytostatic Effects on Human T Leukemia Cells. Toxins. 2016; 8(5): 1-15.
Kumari M, Gupta RP. In Vitro antibacterial effect of Withania somnifera root extract on Escherichia coli. Vet World. 2015; 8(1): 57-60.
Devkar ST, Kandhare AD, Zanwar AA, Jagtap SD, Katyare SS, Bodhankar SL, Hegde MV. Hepatoprotective Effect of Withanolide- Rich Fraction in Acetaminophen-Intoxicated Rat: Decisive Role of TNF-α, IL-1β, COX-II and iNOS. Pharm. Biol. 2016; 54(11): 2394- 2403.
Shah RA, Khan S, Vakil M, Qureshi MT. Evaluation of Anti-diabetic Potential of Withania somnifera by Glucose Uptake Assay on 3T3 F442A Fibroblast (adipocyte cells). Int J Pharm Sci Res. 2017; 8(1): 120-125.
Dhanani T, Shah S, Gajbhiye NA, Kumar S. Effect of Extraction Methods on Yield, Phytochemical Constituents and Antioxidant Activity of Withania somnifera. Arab J Chem. 2017; 10: S1193-S1199.
Gupta M, Kaur G. Withania somnifera as a Potential Anxiolytic and Anti-inflammatory Candidate Against Systemic Lipopolysaccharide-induced Neuroinflammation. Neuromolecular Med. 2018;20(3):343-362.
Choudhary B, Shetty A, Langade DG. Efficacy of Ashwagandha (Withania somnifera [L] Dunal) in Improving Cardiorespiratory Endurance in Healthy Athletic Adults. Ayu. 2015; 36(1): 63-68.
Khan MA, Subramaneyaan M, Arora VK, Banerjee BD, Ahmed RS. Effect of Withania somnifera (Ashwagandha) Root Extract on Amelioration of Oxidative Stress and Autoantibodies Production in Collagen-Induced Arthritic Rats. J Complement Integr Med. 2015; 12(2): 117-125.
Birla H, Keswani C, Rai SN, Singh SS, Zahra W, Dilnashin H, Rathore AS, Singh SP. Neuroprotective Effects of Withania somnifera in BPA Induced-Cognitive Dysfunction and Oxidative Stress in Mice. Behav Brain Funct. 2019; 15(1): 1-9.
Rizvi TF, Razauddin M, Urrahman MS, Jahan T, Naz Z, Kumar R, Kumar A, Ali M. Immunomodulatory Effect of Aswagandha Against Doxorubicin Toxicity. Eur J Pharm Med Res. 2016; 3(7): 463-467.
Tekula S, Khurana A, Anchi A, Godugu C. Withaferin-A Attenuates Multiple Low Doses of Streptozotocin (MLD-STZ) Induced Type 1 Diabetes. Biomed Pharmacother. 2018; 106, 1428-1440.
Kaur T, Singh H, Mishra R, Manchanda S, Gupta M, Saini V, Sharma A, Kaur G. Withania somnifera as a Potential Anxiolytic and Immunomodulatory Agent in Acute Sleep Deprived Female Wistar Rats. Mol Cell Biochem. 2016; 427(1-2): 91-101.
Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Jarvinen H, Van Haeften T, Renn W, Gerich J. Use of the Oral Glucose Tolerance Test to Assess Insulin Release and Insulin Sensitivity. Diabetes Care. 2000; 23(3): 295-301.
Gauttam V K, K alia A N. D evelopment o f P olyherbal A ntidiabetic Formulation Encapsulated in the Phospholipids Vesicle System. J Adv Pharm Tech Res. 2013; 4(2): 108-117.
Baron AD. Postprandial Hyperglycaemia and α-Glucosidase Inhibitors. Siab Res Clin Pract. 1998; 40: S51-S55.
Botham P. Acute Systemic Toxicity-Prospects for Tiered Testing Strategies. Toxicol In Vitro. 2004; 18: 227-230.
Sarwar M, Attitalla IH, Abdollahi M. A Review on the Recent Advances in Pharmacological Studies on Medicinal Plants: Animal Studies are done but Clinical Studies Needs Completing. Asian J Anim Vet Adv. 2011; 6(8): 867-883.
Chowdhury MAZ, Hossain MI, Hossain MS, Ahmed S, Afrin T, Karim N. Antidiabetic Effects of Momordica charantia (Karela) in Male Long Evans Rat. J Adv Lab Res Biol. 2012; 3(3): 175-180.
Pahlavani N , R oudi F , Z akerian M , F erns G A, N avashenaq J G, Mashkouri A, Mobarhan MG, Rahimi H. Possible Molecular Mechanisms of Glucose-Lowring Activities of Momordica charantia (Karela) in diabetes. J Cell Biochem. 2019; 1-9.
Nugroho AE, Rais IR, Setiawan I, Pratiwi PY, Hadibarata T, Tegar M, Pramono S. Pancreatic effect of andrographolide isolated from Andrographis paniculata (Burm. F.) Nees. Pak J Biol Sci. 2014; 17(1): 22-31.
Udayakumar R, Kasthurirengan S, Mariashibu TS, Rajesh M, Anbazhagan VR, Kim SC, Ganapathi A, Choi CW. Hypoglycaemic and Hypolipidaemic Effects of Withania somnifera Root and Leaf of Extracts on Alloxan-Induced Diabetic Rats. Int J Mol Sci. 2009; 10: 2367-2382.
Joseph B, Jini D. Antidiabetic Effects of Momordica charantia (bitter melon) and its Medicinal Potency. Asian Pac J Trop Dis. 2013; 3(2): 93-102.
Islam MT. Andrographolide, a New Hope in the Prevention and Treatment of Metabolic Syndrome. Front Pharamcol. 2017; 8(571): 1-9.
Gorelick J, Rosenberg R, Smotrich A, Hanus L, Bernstein N. Hypoglycemic Activity of Withanolides and Elicitated Withania somnifera. Phytochemistry. 2015; 116: 283-289.
Published
Abstract Display: 652 
PDF Downloads: 476 
